156 related articles for article (PubMed ID: 16374565)
1. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients.
Chamoun RB; Alaraj AM; Al Kutoubi AO; Abboud MR; Haddad GF
Acta Neurochir (Wien); 2006 Feb; 148(2):175-9; discussion 180. PubMed ID: 16374565
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
Chamberlain MC
Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of temozolomide chemotherapy for intramedullary grade II spinal cord astrocytomas in adults: Our experience].
Chaskis E; Minichini V; Luce S; Devriendt D; Goldman S; De Witte O; Sadeghi N; Lefranc F
Neurochirurgie; 2017 Sep; 63(4):297-301. PubMed ID: 28882604
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
[TBL] [Abstract][Full Text] [Related]
6. Spinal intradural primary germ cell tumour--review of literature and case report.
Biswas A; Puri T; Goyal S; Gupta R; Eesa M; Julka PK; Rath GK
Acta Neurochir (Wien); 2009 Mar; 151(3):277-84. PubMed ID: 19240975
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in intramedullary astrocytomas: a literature review.
Benes V; Barsa P; Benes V; Suchomel P
Eur Spine J; 2009 Oct; 18(10):1397-422. PubMed ID: 19562388
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
10. Intramedullary spinal cord astrocytomas in children.
Townsend N; Handler M; Fleitz J; Foreman N
Pediatr Blood Cancer; 2004 Nov; 43(6):629-32. PubMed ID: 15390309
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for spinal cord astrocytoma: can natural history be modified?
Lowis SP; Pizer BL; Coakham H; Nelson RJ; Bouffet E
Childs Nerv Syst; 1998 Jul; 14(7):317-21. PubMed ID: 9726582
[TBL] [Abstract][Full Text] [Related]
12. Pseudoprogression after radiotherapy with concurrent temozolomide in a child with anaplastic astrocytoma.
Ozdemir N; Celkan T
Pediatr Hematol Oncol; 2010 May; 27(4):317-9. PubMed ID: 20426523
[No Abstract] [Full Text] [Related]
13. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
14. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
15. [Temozolomide in the treatment of recurrent malignant glioma].
Kobayashi H; Sawamura Y; Ishii N; Murata J; Iwasaki Y
No Shinkei Geka; 2006 Dec; 34(12):1241-7. PubMed ID: 17154070
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
van den Bent MJ; Taphoorn MJ; Brandes AA; Menten J; Stupp R; Frenay M; Chinot O; Kros JM; van der Rijt CC; Vecht ChJ; Allgeier A; Gorlia T;
J Clin Oncol; 2003 Jul; 21(13):2525-8. PubMed ID: 12829671
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.
Baruchel S; Diezi M; Hargrave D; Stempak D; Gammon J; Moghrabi A; Coppes MJ; Fernandez CV; Bouffet E
Eur J Cancer; 2006 Sep; 42(14):2335-42. PubMed ID: 16899365
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
Chamberlain MC; Tsao-Wei DD; Groshen S
Cancer; 2006 Jan; 106(1):172-9. PubMed ID: 16323194
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
Wick A; Felsberg J; Steinbach JP; Herrlinger U; Platten M; Blaschke B; Meyermann R; Reifenberger G; Weller M; Wick W
J Clin Oncol; 2007 Aug; 25(22):3357-61. PubMed ID: 17664483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
